Efficacy and safety of the oral Janus kinase 1 inhibitor povorcitinib (INCB054707) in patients with hidradenitis suppurativa in a phase 2, randomized, double-blind, dose-ranging, placebo-controlled study
Kirby, Joslyn S., Okun, Martin M., Alavi, Afsaneh, Bechara, Falk G., Zouboulis, Christos C., Brown, Kurt, Santos, Leandro L., Wang, Annie, Bibeau, Kristen B., Kimball, Alexa B., Porter, Martina L.
Published in Journal of the American Academy of Dermatology (01.03.2024)
Published in Journal of the American Academy of Dermatology (01.03.2024)
Get full text
Journal Article
Incidence of type 2 diabetes among patients exposed to the combination of pravastatin and paroxetine
Gooden, Kyna M, Bibeau, Kristen B, Wood, Jennifer, Irizarry, Michael C, Pan, Xianying, Allen, Jeffery, Sampson, Tim, Heim, Jean-Marie
Published in Current drug safety (01.01.2015)
Published in Current drug safety (01.01.2015)
Get more information
Journal Article